| G Werber Bryan Psych Hosp | |
| 220 Faison Dr, Columbia, South Carolina 29203 | |
| (803) 935-7143 | |
| Not Available |
| Name | G Werber Bryan Psych Hosp |
|---|---|
| Type | Psychiatric Hospital |
| Location | 220 Faison Dr, Columbia, South Carolina |
| Ownership | Government - State |
| Emergency Services | No |
| Medicare ID (CCN) | 424005 |
| NPI Number | 1265452619 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | G. WERBER BRYAN PSYCHIATRIC HOSPITAL |
| Address | 220 Faison Dr, Columbia, SC 29203 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 803-898-8405 |
News Archive
In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.
Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
› Verified 1 days ago
| NPI Number | 1295785137 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | G. WERBER BRYAN PSYCHIATRIC |
| Address | 220 Faison Dr, Columbia, SC 29203 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 803-898-1662 |
News Archive
In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.
Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
› Verified 1 days ago
| NPI Number | 1356487607 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | G. WERBER BRYAN PSYCHIATRIC HOSPITAL PHARMACY |
| Address | 220 Faison Dr, Columbia, SC 29203 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 803-935-7154 |
News Archive
In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.
Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
› Verified 1 days ago
| NPI Number | 1437174919 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | G. WERBER BRYAN PSYCHIATRIC |
| Address | 220 Faison Dr, Columbia, SC 29203 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 803-898-1662 |
News Archive
In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.
Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
› Verified 1 days ago
| NPI Number | 1609825264 |
| Organization Name | SOUTH CAROLINA DEPT OF MENTAL HEALTH ACCOUNTING OFFICE |
| Doing Business As | G. WERBER BRYAN PSYCHIATRIC HOSPITAL |
| Address | 220 Faison Dr, Columbia, SC 29203 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 803-898-8405 |
News Archive
In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.
Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
› Verified 1 days ago
News Archive
In recent years, a deficiency of vitamin D has been linked to type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Both disorders are rooted in chronic inflammation, which leads to insulin resistance and the buildup of artery-clogging plaque.
Cellectis, the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro 38 million in cash reserves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
› Verified 1 days ago
Prisma Health Richland Hospital Acute Care Hospital Location: 5 Medical Park, Columbia, South Carolina 29203 Phone: (803) 296-2548 | |
Providence Health Acute Care Hospital Location: 120 Gateway Corporate Blvd, Columbia, South Carolina 29203 Phone: (803) 256-5300 | |
Prisma Health Baptist Acute Care Hospital Location: 1330 Taylor At Marion St, Columbia, South Carolina 29220 Phone: (803) 296-5678 | |
Prisma Health Baptist Parkridge Acute Care Hospital Location: 400 Palmetto Health Parkway, Columbia, South Carolina 29212 Phone: (803) 907-7011 | |
G Werber Bryan Psych Hosp Psychiatric Hospital Location: 220 Faison Dr, Columbia, South Carolina 29203 Phone: (803) 935-7143 |